Deutsche Bank Ag\ Supernus Pharmaceuticals, Inc. Transaction History

Deutsche Bank Ag\

$248 Billion
Q4 2024

A detailed history of Deutsche Bank Ag\ transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 105,583 shares of SUPN stock, worth $3.29 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

105,583

Previous 32,370 226.18%

Holding current value

$3.29 Million

Previous $1.01 Million 278.3%

% of portfolio

0.0%

Previous 0.0%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$31.89 - $37.83 $2.33 Million - $2.77 Million	73,213 Added 226.18%	105,583 $3.82 Million
Q3 2024 Nov 13, 2024	BUY	$25.77 - $35.16 $172,942 - $235,958	6,711 Added 26.15%	32,370 $1.01 Million
Q2 2024 Aug 14, 2024	SELL	$25.99 - $33.85 $137,591 - $179,201	-5,294 Reduced 17.1%	25,659 $686,000
Q1 2024 May 15, 2024	BUY	$27.11 - $35.17 $116,789 - $151,512	4,308 Added 16.17%	30,953 $1.06 Million
Q4 2023 Feb 14, 2024	SELL	$22.72 - $29.68 $14,972 - $19,559	-659 Reduced 2.41%	26,645 $771,000
Q3 2023 Nov 09, 2023	BUY	$27.57 - $32.91 $84,970 - $101,428	3,082 Added 12.72%	27,304 $752,000
Q2 2023 Aug 14, 2023	SELL	$29.91 - $38.73 $290,456 - $376,107	-9,711 Reduced 28.62%	24,222 $728,000
Q1 2023 May 15, 2023	BUY	$34.93 - $42.03 $324,255 - $390,164	9,283 Added 37.66%	33,933 $1.23 Million
Q4 2022 Feb 13, 2023	BUY	$31.09 - $37.88 $77,818 - $94,813	2,503 Added 11.3%	24,650 $879,000
Q3 2022 Nov 14, 2022	SELL	$28.79 - $35.41 $1.25 Million - $1.54 Million	-43,567 Reduced 66.3%	22,147 $749,000
Q2 2022 Aug 11, 2022	SELL	$25.33 - $34.25 $4.15 Million - $5.62 Million	-163,970 Reduced 71.39%	65,714 $1.9 Million
Q1 2022 May 13, 2022	SELL	$28.51 - $32.9 $1.54 Million - $1.78 Million	-53,991 Reduced 19.03%	229,684 $7.42 Million
Q4 2021 Feb 11, 2022	BUY	$26.37 - $34.22 $731,108 - $948,749	27,725 Added 10.83%	283,675 $8.27 Million
Q3 2021 Nov 04, 2021	SELL	$23.54 - $31.39 $2.68 Million - $3.57 Million	-113,678 Reduced 30.75%	255,950 $6.83 Million
Q2 2021 Aug 11, 2021	BUY	$26.72 - $33.19 $3.1 Million - $3.84 Million	115,840 Added 45.64%	369,628 $11.4 Million
Q1 2021 May 13, 2021	BUY	$24.15 - $31.45 $114,060 - $148,538	4,723 Added 1.9%	253,788 $6.64 Million
Q4 2020 Feb 16, 2021	BUY	$17.7 - $25.81 $753,135 - $1.1 Million	42,550 Added 20.6%	249,065 $6.27 Million
Q3 2020 Nov 12, 2020	SELL	$20.2 - $25.05 $1.38 Million - $1.71 Million	-68,390 Reduced 24.88%	206,515 $4.3 Million
Q2 2020 Aug 13, 2020	BUY	$17.09 - $24.89 $2.52 Million - $3.67 Million	147,445 Added 115.68%	274,905 $6.53 Million
Q1 2020 May 14, 2020	SELL	$14.45 - $24.69 $3.59 Million - $6.14 Million	-248,610 Reduced 66.11%	127,460 $2.29 Million
Q4 2019 Feb 14, 2020	BUY	$19.93 - $29.13 $268,058 - $391,798	13,450 Added 3.71%	376,070 $8.92 Million
Q3 2019 Nov 14, 2019	SELL	$25.47 - $33.37 $1.82 Million - $2.38 Million	-71,377 Reduced 16.45%	362,620 $9.96 Million
Q2 2019 Aug 14, 2019	SELL	$29.96 - $38.87 $832,109 - $1.08 Million	-27,774 Reduced 6.01%	433,997 $14.4 Million
Q1 2019 May 15, 2019	SELL	$32.77 - $41.99 $1.16 Million - $1.48 Million	-35,344 Reduced 7.11%	461,771 $16.2 Million
Q4 2018 Feb 14, 2019	SELL	$30.84 - $49.51 $3.5 Million - $5.63 Million	-113,641 Reduced 18.61%	497,115 $16.5 Million
Q3 2018 Dec 21, 2021	BUY	$42.7 - $56.55 $1.84 Million - $2.44 Million	43,186 Added 7.61%	610,756 $30.8 Million
Q3 2018 Nov 14, 2018	SELL	$42.7 - $56.55 $10.2 Million - $13.5 Million	-238,331 Reduced 29.57%	567,570 $28.6 Million
Q2 2018 Apr 21, 2020	BUY	$44.1 - $59.85 $5 Million - $6.79 Million	113,435 Added 16.38%	805,901 $48.2 Million
Q2 2018 Aug 14, 2018	BUY	$44.1 - $59.85 $21 Million - $28.5 Million	476,695 Added 220.93%	692,466 $41.4 Million
Q1 2018 Oct 18, 2019	BUY	$37.15 - $46.9 $5.19 Million - $6.55 Million	139,735 Added 183.77%	215,771 $9.88 Million
Q1 2018 May 15, 2018	SELL	$37.15 - $46.9 $3.87 Million - $4.89 Million	-104,197 Reduced 57.81%	76,036 $3.48 Million
Q4 2017 Feb 14, 2018	SELL	$36.4 - $42.6 $5.77 Million - $6.75 Million	-158,459 Reduced 46.79%	180,233 $7.18 Million
Q3 2017 Nov 14, 2017	BUY	$36.75 - $49.65 $12.4 Million - $16.8 Million	338,692	338,692 $13.5 Million

Others Institutions Holding SUPN

# of Institutions

303

Shares Held

60.7M

Call Options Held

22.3K

Put Options Held

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.67B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account